Kintara Therapeutics Inc (NASDAQ:KTRA) has a beta value of 0.80 and has seen 4.83 million shares traded in the last trading session. The company, currently valued at $12.63M, closed the last trade at $0.23 per share which meant it gained $0.03 on the day or 14.70% during that session. The KTRA stock price is -1895.65% off its 52-week high price of $4.59 and 65.22% above the 52-week low of $0.08. If we look at the company’s 10-day average daily trading volume, we find that it stood at 1.67 million shares traded. The 3-month trading volume is 2.77 million shares.
The consensus among analysts is that Kintara Therapeutics Inc (KTRA) is Buy stock at the moment, with a recommendation rating of 2.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 2 out of 6 have rated it as a Hold, with 4 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is 0.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Kintara Therapeutics Inc (NASDAQ:KTRA) trade information
Sporting 14.70% in the green in last session, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the KTRA stock price touched $0.23 or saw a rise of 4.13%. Year-to-date, Kintara Therapeutics Inc shares have moved 33.84%, while the 5-day performance has seen it change 20.11%. Over the past 30 days, the shares of Kintara Therapeutics Inc (NASDAQ:KTRA) have changed 34.88%. Short interest in the company has seen 5.43 million shares shorted with days to cover at 1.14.
Kintara Therapeutics Inc (KTRA) estimates and forecasts
The company’s shares have gained 111.95% over the past 6 months.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 71.02% over the past 5 years.
KTRA Dividends
Kintara Therapeutics Inc is expected to release its next earnings report in November this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Kintara Therapeutics Inc (NASDAQ:KTRA)’s Major holders
Insiders own 0.12% of the company shares, while shares held by institutions stand at 1.47% with a share float percentage of 1.47%. Investors are also buoyed by the number of investors in a company, with Kintara Therapeutics Inc having a total of 17.0 institutions that hold shares in the company.
Also the top two Mutual Funds that are holding company’s shares are Fidelity Extended Market Index Fund and Fidelity Series Total Market Index Fund . As of Aug 31, 2024 , the former fund manager holds about 0.54% shares in the company for having 303.02 shares of worth $68786.0 while later fund manager owns 54.12 shares of worth $12285.0 as of Aug 31, 2024 , which makes it owner of about 0.10% of company’s outstanding stock.
